• 목록
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or keep ADHD medication during pregnancy and nursing is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these medications may affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological developmental disorders such as hearing loss or impaired vision, febrile seizures, or IQ impairment. The authors acknowledge that more high-quality research is needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication need to evaluate the benefits of using it against the possible dangers for the fetus. Doctors don't have enough data to provide clear recommendations but they can provide information on risks and benefits to assist pregnant women to make informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during their early pregnancy did not face a significantly increased risk of fetal heart malformations or major birth defects that are structural. Researchers used a large population-based case control study to assess the frequency of major structural defects in infants who were born to mothers who used stimulants during pregnancy. Clinical geneticists, pediatric cardiologists and other experts examined the cases to confirm that the classification was accurate and to minimize any bias.

The study conducted by the researchers was not without limitations. The researchers were unable, in the first place to differentiate the effects caused by the medication from the disorder. This makes it difficult to determine whether the limited associations observed in the groups that were exposed are due to the use of medication or confounding by comorbidities. In addition, the researchers did not look at the long-term outcomes of offspring.

The study found that infants whose mother took ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU), compared to those whose mothers didn't take any medication during pregnancy or quit taking the medication prior to or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not affected by the stimulant medication used during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an elevated chance of having a caesarean section or having a baby born with a low Apgar score (less than 7). These increases appeared to be independent of the type of medication used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications in early pregnancies can be offset by more beneficial outcomes for both mother and baby of continuing treatment for the woman's condition. Physicians should talk to their patients about this issue and as much as possible, assist them develop coping strategies that can lessen the impact of her disorder in her daily life and relationships.

Medication Interactions

As more women than ever are being diagnosed with ADHD and being treated with medication, the issue of whether to keep or stop treatment during pregnancy is one that more and more doctors confront. Most of the time, these decisions are made in the absence of clear and authoritative evidence in either case, which means that doctors must weigh what they know about their experiences, the experiences of other doctors, and what research suggests about the subject, along with their own best judgment for each individual patient.

Particularly, the subject of potential risks for the baby can be a challenge. The research that has been conducted on this topic is based on observation rather than controlled studies, and a lot of the results are conflicting. Additionally, the majority of studies limit their analysis to live births, which can underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study discussed in this journal club addresses these issues by examining data on both live and deceased births.

The conclusion: While certain studies have demonstrated a positive association between ADHD medications and the risk of certain birth defects, other studies have found no connection, and most studies demonstrate a neutral or slight negative effect. In every case an in-depth analysis of the risks and benefits is required.

For women suffering from ADHD, the decision to discontinue medication can be difficult, if not impossible. In fact, in an article published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation, and family conflict for those suffering from the disorder. Additionally, the loss of medication can interfere with the ability to complete work-related tasks and safely drive that are crucial aspects of daily life for many people with ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy should educate family members, coworkers and their friends about the condition, its impact on daily functioning and the benefits of continuing the current treatment regimen. In addition, educating them can make the woman feel more comfortable as she struggles with her decision. Certain medications can be passed through the placenta. If the patient decides to not take her adhd medication brands uk medication while breastfeeding, it is crucial to be aware that the medication could be passed on to her baby.

Birth Defects Risk

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns about the effects that the medications could have on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Researchers utilized two massive datasets to analyze over the counter adhd medication for adults 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. While the overall risk is low, the researchers found that exposure in the first trimester to ADHD medications was linked to a slightly higher rate of certain heart defects such as ventriculo-septal defect (VSD).

The researchers of the study found no association between early medication use and congenital abnormalities such as facial clefting or club foot. The findings are in line with previous studies showing a small but significant increase in the risk of heart malformations among women who began taking ADHD medications prior to the time of pregnancy. The risk grew during the latter part of pregnancy, as many women decide to stop taking their ADHD medication.

Women who took ADHD medications during the first trimester of their pregnancy were also more likely to have a caesarean section, a low Apgar score following delivery, and a baby who required breathing assistance at birth. However the researchers of the study were not able to eliminate bias due to selection by restricting the study to women who did not have other medical issues that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they meet pregnant women. They suggest that although discussing the benefits and risks is important, the decision to stop or keep treatment should be based on the woman's requirements and the severity of her ADHD symptoms.

The authors also warn that while discontinuing the medications is an option, it is not an option to consider due to the high rate of depression and other mental health issues for women who are expecting or postpartum. Furthermore, research suggests that women who decide to stop their medications are more likely to experience difficulties adjusting to life without them following the baby's arrival.

Nursing

It can be overwhelming to become a mother. Women suffering from ADHD may face a lot of challenges when they have to manage their symptoms, attend doctor appointments and prepare for the birth of a child and adjust to new routines. Therefore, many women elect to continue taking their ADHD medications throughout the course of pregnancy.

The risk to a breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk at low levels. The rate of exposure to medication will vary based on the dosage and frequency of administration as well as the time of day. In addition, various drugs enter the infant's system through the gastrointestinal tract, or through breast milk. The impact on the health of a newborn is not fully understood.

Due to the absence of research, some physicians may be inclined to discontinue stimulant drugs during the pregnancy of a woman. It is a difficult decision for the woman who must weigh the benefits of her medication against the risks to the embryo. As long as more information is available, doctors can inquire about pregnant patients if they have a background of ADHD or if they intend to take medication in the perinatal stage.

Numerous studies have demonstrated that women can continue taking their adhd medication prescription uk medication in a safe manner during pregnancy and breast-feeding. As a result, more and more patients choose to do so and, in consultation with their physician, they have discovered that the benefits of continuing their current medication outweigh any risks.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should discuss their medication with their prescriber and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological management strategies. Psychoeducation is also needed to help pregnant women with adhd and depression medication (by Wownsk Portal) recognize the signs and the underlying disorder. They should also learn about treatment options and strengthen the coping mechanisms. This should include an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, as well as monitoring for signs of deterioration, and, if needed adjustments to the medication regime.